The increasing interest in potent weight management has resulted in considerable research into groundbreaking treatments. Lately , Retatrutide, a dual -action GIP and glucagon-like peptide-1 (GLP-1) receptor agonist , has demonstrated promising results in patient trials, indicating potential for considerable weight decrease. Therefore, numerous ind